Long COVID Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with COVID-19 and still have ongoing problems with their sense of smell
- People who are willing and able to sign a written consent form
- People who can read and understand French
- People who have access to the internet and a working email address
Who may not be able to join:
- People who had a reduced or absent sense of smell before getting COVID-19
- People with a known long-term condition affecting the sinuses, with or without nasal polyps
- People who have previously received radiation therapy or chemotherapy for a cancer of the head or neck
- People who have been diagnosed with Alzheimer's disease, Parkinson's disease, multiple sclerosis, or any other condition that causes progressive damage to the nervous system
- People who have been diagnosed with a brain tumour or a condition affecting the ear, nose, or throat (confirm with trial site)
- People who have had surgery on the nose or sinuses in the past
- People who have had a traumatic brain injury in the past
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Johannes A Frasnelli, PhD, Université du Québec à Trois-Rivières
Phone: 18193765011
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes from baseline in olfactory score on the University of Pennsylvania Identification Test (UPSIT) [ Time Frame: Measurement will be taken at time zero (pre-intervention) and 12 weeks (post-intervention); Changes from baseline in olfactory score on the Sniffin's Sticks test; n-house test for chemosensory dysfunction (TMSC); Parosmia and phantosmia assessment test; The abridged version of the Questionnaire of Olfactory Disorders - Negative Statements (sQOD-NS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.